XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 31.16

-3.2%

Dec 1 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bluegreen who wrote (16464)	11/22/2003 10:07:10 AM
From: Robert K.	of 17367

Blue> look at all the people getting long term prednisone. How do you spell bone-loss and ulcers and other problems. What conditions does prednisone & mtx & cyclosporin treat? Enbrel is just starting to move in. Enbrel has actually done XOMA a huge favor by breaking ground for us. Raptiva is being COMPARED to enbrel ALREADY. Cacaito, seems like amevive is ALREADY a afterthought. Raptiva is JUST getting its feet wet in this monster market. Let them compare enbrel and raptiva to death. Its good PR for Raptiva and xoma. Oh, and lets talk asthma, hiv, lupus, MS etc etc etc. You can BET YOUR ASS the partnership is moving silently on some or many of these as i type. But dont bet your ass, vbg. no facts. skd.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next